We are pleased to invite you to join us this fall for the 16th Annual Diabetes Technology Meeting, from November 10 to November 12, 2016, at the Bethesda North Marriott Hotel & Conference Center in Bethesda, Maryland.
This will be an excellent opportunity to meet leading scientists in the field of diabetes research and learn about the latest technological advances for people with diabetes. Last year’s meeting in Bethesda, Maryland brought together over 450 clinicians and scientists from 24 countries to focus on applying science and technology to fight diabetes.
The meeting’s goal is to assemble technology developers and users to facilitate creation of new and cost-effective tools - including an artificial pancreas - to help people with diabetes. The meeting will particularly emphasize original data. Scientists and clinicians will have plenty of opportunities to share ideas in both formal and informal settings, and gain insight into how to help decrease the physical and psychological burden of diabetes.
The format will include state-of-the-art lectures, oral presentations of abstracts, panel discussions with Q & A sessions, and two poster sessions. A syllabus of the submitted abstracts will be distributed to all attendees.
Every attendee will receive a 1-year subscription to Journal of Diabetes Science and Technology. This peer-reviewed bimonthly scientific journal is indexed by the National Library of Medicine for MEDLINE/PubMed and is the world’s first purely electronic diabetes journal (www.jdst.org).
We look forward to seeing you in Bethesda and sharing information about projects of mutual interest.
Following this course, participants should be able to:
Evaluate the performance of diabetes technologies and identify principles for selecting, combining, and advancing therapy using technology.
Explain how to motivate patients to use the latest diabetes technologies to improve outcomes.
Assess the utility of self-monitoring of blood glucose (SMBG) methods in improving management of difficult-to-treat patients.
Assess the utility of continuous glucose monitoring (CGM) in improving management of difficult-to-treat patients.
Assess the utility of insulin pump therapy and insulin dose calculators in improving management of difficult-to-treat patients.
Enhance strategies to use technology to increase the effectiveness of lifestyle interventions, such as food plans, weight management, and physical activity for diabetes management.
Initiate insulin therapy and adjust insulin doses based on glycemic pattern recognition.
Recognize clinical situations where SMBG, CGM, or insulin pump therapy can improve outcomes and well-being for diabetes patients.
Outline a systematic approach using technology for managing diabetes, diabetes complications, and complex medication regimens.
Understand the scientific and engineering principles that support SMBG, CGM, and insulin pumps.
Modify diabetes management for special populations, such as senior, pediatric, and pregnant patients using advanced diabetes technologies.
Summarize new technologies that may be available in the next 5 years for management of hyperglycemia.
Diabetes Technology Society (DTS) is a nonprofit organization committed to promoting development and use of technology in the fight against diabetes. DTS was established in 2001 by David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE, Clinical Professor of Medicine at University of California, San Francisco (CV).